These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21802914)

  • 21. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
    Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.
    Schroen AT; Cress RD
    Ann Surg; 2001 Nov; 234(5):641-51. PubMed ID: 11685027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receipt of recommended therapy by patients with advanced colorectal cancer.
    Abraham NS; Gossey JT; Davila JA; Al-Oudat S; Kramer JK
    Am J Gastroenterol; 2006 Jun; 101(6):1320-8. PubMed ID: 16771956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the effectiveness of a guideline recommendation for pre-operative radiochemotherapy in rectal cancer.
    Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
    Radiother Oncol; 2011 May; 99(2):142-7. PubMed ID: 21571385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008.
    Boll D; Verhoeven RH; van der Aa MA; Lybeert ML; Coebergh JW; Janssen-Heijnen ML
    Eur J Cancer; 2011 Jul; 47(10):1504-10. PubMed ID: 21530238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
    McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
    Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
    Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
    Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy in colorectal cancer.
    Parshad R
    Trop Gastroenterol; 1997; 18(4):139-44. PubMed ID: 9612092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
    Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of pelvic radiation in stage II rectal cancer: a population-based analysis.
    Kuo I; Wong JH; Roy-Chowdhury S; Lum SS; Morgan JW; Kazanjian K
    Am Surg; 2010 Oct; 76(10):1092-5. PubMed ID: 21105617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
    Cheung WY; Neville BA; Earle CC
    Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.
    Shimada Y; Takii Y; Maruyama S; Ohta T
    Dis Colon Rectum; 2011 Dec; 54(12):1510-20. PubMed ID: 22067179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual treatment disparities after oncology referral for rectal cancer.
    Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
    J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum.
    VanEenwyk J; Campo JS; Ossiander EM
    Cancer; 2002 Jul; 95(1):39-46. PubMed ID: 12115315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
    Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
    Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.